April 22, 2026 · Form 4 insider transaction
Aminov Erez bought 7,319,710 shares of Telomir Pharmaceuticals, Inc. at $1.37 per share, a transaction worth $10.03M. The trade was recorded as j and disclosed on an SEC Form 4, filed 2 days after the transaction.
The shares of common stock, no par value of the Issuer issued to the Reporting Person are in exchange for the Reporting Person's shares of TELI Pharmaceuticals, Inc. ("TELI") in connection with the Issuer's acquisition of TELI.